U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07602049) titled 'Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma' on May 08.
Brief Summary: The main purpose of this trial is to investigate and evaluate the efficacy of cryoablation combined with camrelizumab treatment to patients with advanced or inoperable soft tissue sarcomas after standard treatment failure.
Study Start Date: Nov. 20, 2024
Study Type: INTERVENTIONAL
Condition:
Soft Tissue Sarcoma (STS)
Osteosarcoma
Intervention:
DRUG: Cryoablation therapy + anti-PD-1 antibody
All enrolled patients undergo local cryoablation combined with camrelizumab treatment. Baseline evaluations are carried out for all lesions throughou...